201530-79-2: Deferasirox Ethyl Ester

201530-79-2: Deferasirox Ethyl Ester

?Deferasirox Ethyl Ester CAS No.: 201530-79-2 with IUPAC Name 4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]-benzoic Acid Ethyl Ester is an impurity of Deferasirox which is mainly used to reduce chronic iron overload in patients receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. The first oral medication approved in the United States for this purpose is Deferasirox

Additional information on CAS 201530-79-2

Catalogue No.

VE008733
CAS No.

201530-79-2
Molecular Formula

C23H19N3O4
Molecular Weight

401.41 g/mol
Parent drug

Deferasirox
IUPAC Name

4-[3, 5-Bis(2-hydroxyphenyl)-1H-1, 2, 4-triazol-1-yl]-benzoic Acid Ethyl Ester
Synonyms

N/A
References

Choudhry, V. P., and Rahul Naithani. “Current Status of Iron Overload and Chelation with Deferasirox.” The Indian Journal of Pediatrics, vol. 74, no. 8, Aug. 2007, pp. 759–64, https://doi.org/10.1007/s12098-007-0134-7.
Status

In-stock

Other products related to deferasirox

[rfq_list]

Login first to add product to RFQ List

Request a quote

201530-79-2: Deferasirox Ethyl Ester

201530-79-2: Deferasirox Ethyl Ester
Catalogue No.

VE008733
CAS No.

201530-79-2
Molecular Formula

C23H19N3O4
Molecular Weight

401.41 g/mol
Parent drug

Deferasirox
IUPAC Name

4-[3, 5-Bis(2-hydroxyphenyl)-1H-1, 2, 4-triazol-1-yl]-benzoic Acid Ethyl Ester
Synonyms

N/A
References

Choudhry, V. P., and Rahul Naithani. “Current Status of Iron Overload and Chelation with Deferasirox.” The Indian Journal of Pediatrics, vol. 74, no. 8, Aug. 2007, pp. 759–64, https://doi.org/10.1007/s12098-007-0134-7.
Status

In-stock
ListName

Deferasirox Ethyl Ester
Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden